1. Aggarwal, G., Ramachandran, V., Javeed, N., Arumugam, T., Dutta, S., Klee, G.G., Klee, E.W., Smyrk, T.C., Bamlet, W., Han, J.J., Vittar, N.B.R., De Andrade, M., Mukhopadhyay, D., Petersen, G.M., Fernandez-Zapico, M.E., et al. (2012) Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. Gastroenterology, 143, 1510-1517. e1.
2. American Diabetes Association (2018) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care, 41, S13-S27.
3. Amin, M.B., Edge, S., Greene, F., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., Sullivan, D.C., Jessup, J.M., Brierley, J.D., Gaspar, L.E., Schilsky, R.L., Balch, C.M. et al. (2017) AJCC Cancer Staging Manual, 8th ed., Springer International Publishing, NY, USA.
4. Aslanian, H.R., Lee, J.H. & Canto, M.I. (2020) AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review. Gastroenterology, 159, 358-362.
5. Batabyal, P., Vander Hoorn, S., Christophi, C. & Nikfarjam, M. (2014) Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann. Surg. Oncol., 21, 2453-2462.